ArticleHuman vaccines & immunotherapeutics2024

Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France.

Amy Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.